top of page
Search

Lancet Neurology - Landmark Paper Published

  • Writer: Center for Neurologic Study
    Center for Neurologic Study
  • Nov 10, 2020
  • 1 min read

Lancet Neurology publishes landmark paper of a potential therapy for ALS developed in collaboration with UCSD and Isis Pharmaceutical Co: "An Antisense Oligonucleotide against SOD1 Delivered Intrathecally for Patients with SOD1-Familial Amyotrophic Lateral Sclerosis: a phase 1, randomized, first-in man study."

 
 
 

Comments

© 2021 by Center for Neurologic Study.

bottom of page